[go: up one dir, main page]

Syntenins

"Syntenins" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure, which enables searching at various levels of specificity.

expand / collapse MeSH information
Intracellular signaling adaptor proteins that play a role in the coupling of SYNDECANS to CYTOSKELETAL PROTEINS.


expand / collapse Publications
This graph shows the total number of publications written about "Syntenins" by people in this website by year, and whether "Syntenins" was a major or minor topic of these publications.
Below are the most recent publications written about "Syntenins" by people in Profiles.
  1. MDA-9/Syntenin in the tumor and microenvironment defines prostate cancer bone metastasis. Proc Natl Acad Sci U S A. 2023 Nov 07; 120(45):e2307094120.
    View in: PubMed
  2. Pharmacological inhibition of MDA-9/Syntenin blocks breast cancer metastasis through suppression of IL-1β. Proc Natl Acad Sci U S A. 2021 05 25; 118(21).
    View in: PubMed
  3. MDA-9/Syntenin (SDCBP): Novel gene and therapeutic target for cancer metastasis. Pharmacol Res. 2020 05; 155:104695.
    View in: PubMed
  4. UNC93B1 recruits syntenin-1 to dampen TLR7 signalling and prevent autoimmunity. Nature. 2019 11; 575(7782):366-370.
    View in: PubMed
  5. Rethinking Glioblastoma Therapy: MDA-9/Syntenin Targeted Small Molecule. ACS Chem Neurosci. 2019 03 20; 10(3):1121-1123.
    View in: PubMed
  6. Regulation of protective autophagy in anoikis-resistant glioma stem cells by SDCBP/MDA-9/Syntenin. Autophagy. 2018; 14(10):1845-1846.
    View in: PubMed
  7. MDA-9/Syntenin regulates protective autophagy in anoikis-resistant glioma stem cells. Proc Natl Acad Sci U S A. 2018 05 29; 115(22):5768-5773.
    View in: PubMed
  8. Inhibition of radiation-induced glioblastoma invasion by genetic and pharmacological targeting of MDA-9/Syntenin. Proc Natl Acad Sci U S A. 2017 01 10; 114(2):370-375.
    View in: PubMed
  9. Syntenin-1 is a promoter and prognostic marker of head and neck squamous cell carcinoma invasion and metastasis. Oncotarget. 2016 Dec 13; 7(50):82634-82647.
    View in: PubMed